InvestorsHub Logo
Followers 23
Posts 1982
Boards Moderated 0
Alias Born 09/24/2008

Re: misanthrope post# 250248

Friday, 01/29/2021 7:29:39 PM

Friday, January 29, 2021 7:29:39 PM

Post# of 330260
Misanthrope, than you for your reply. I believe your arguments on supply and demand may lack substantial evidence to back up MM failure to deliver shares. In BIEL case there were not alot of shares available yo buy during the run. The MM sold the shares to buyers from thin air. Taking a chance, hoping that they can buy back the shares when traders exit. So, in my opinion, the MM do have an adverse affect on shares price. No question about it.
In the case of GME, the same thing happen. But the demand was so high, it resulted in a classic MOASS. I will side with JGD for that reason.
As for market cap, JGD has a point. Currently the company worth more than what the PPS indicate. 5 FDA clearance isnt a joke. In fact no company in the pink has that type of resume. Those FDA clearance worth 5 times the current market cap. Now, with the two current partners, we should be in Nickel Country. Thank you again for your reply. Appreciate your thought.

BIEL